24/7 eTV BreakingNews Show : Danna maɓallin ƙara (hagu na hagu na allon bidiyo)
Airlines Airport Aviation Breaking Labaran Turai Breaking Labaran Duniya Yanke Labaran Balaguro Tafiya Kasuwanci Labaran Gwamnati Rahoton Lafiya Ƙasar Abincin Labaran India Labarai mutane Sake ginawa Hakkin Safety Tourism Transport Sabunta Hannun tafiya Labaran Wayar Balaguro trending Yanzu Labarai Da Dumi Duminsu

Indiya na son Burtaniya ta kawar da keɓe masu cutar da Indiyawan da aka yi wa allurar

Indiya na son Burtaniya ta kawar da keɓe masu cutar da Indiyawan da aka yi wa allurar
Indiya na son Burtaniya ta kawar da keɓe masu cutar da Indiyawan da aka yi wa allurar
Written by Harry Johnson

Dokar, wacce ke ba da umarnin keɓe kai na kwanaki 10 ga matafiya da ke zuwa daga Indiya, ta kuma shafi sauran ƙasashe da yawa ta amfani da Covishield, gami da yawancin na Afirka.

Print Friendly, PDF & Email
  • Baƙi masu cikakken allurar rigakafi daga Indiya har yanzu ana buƙatar zuwa keɓewa na kwanaki 10 na COVID-19.
  • Jami'ar Oxford da AstraZeneca ne suka haɓaka maganin Covishield kuma Cibiyar Serum ta Indiya ce ta kera shi.
  • Ba a buƙatar 'yan Burtaniya da aka yiwa allurar rigakafi a Burtaniya tare da irin jabs ɗin da aka yi da Indiya don keɓewa.

Burtaniya ta ba da sanarwar cewa za ta sassauta takunkumin cutar ta COVID-19 don cikakken baƙi masu ba da allurar riga-kafi daga farkon watan gobe.

Amma jerin ƙasashen da aka amince da allurar rigakafi ba ta haɗa da Indiya ba, duk da ƙasar ta yi amfani da sigar gida ta allurar AstraZeneca da aka haɓaka a Burtaniya, kuma tana haifar da rashin kwanciyar hankali na siyasa da barazanar ramuwar gayya daga jami'an Indiya.

Allurar Covishield, wanda Jami’ar Oxford ta haɓaka tare AstraZeneca kuma Cibiyar Serum ta Indiya da ke Pune ta kera ta, Burtaniya ba ta amince da ita ba a karkashin sabuwar dokar duk da cewa ta yi daidai da allurar da aka bai wa miliyoyin 'yan Burtaniya.

The AstraZeneca allurar rigakafi ita ce mafi yawan alluran da aka baiwa Indiyawa har zuwa yau. Ƙananan adadi sun ɗauki allurar rigakafi ta asali ta Bharat Biotech, wacce ba a amfani da ita a Burtaniya.

Ministan harkokin wajen Indiya ya bukaci hukumomin gwamnatin Burtaniya da su “fara warware matsalar keɓewa” da Indiyawan da ke ziyartar su United Kingdomm har yanzu ana buƙatar keɓewa koda kuwa an yi musu cikakken allurar rigakafi.

Sabbin dokokin shigarwa, wanda ya fara aiki a watan Oktoba, ya harzuka Indiyawan da dama, wadanda suka bayyana hukuncin a matsayin nuna wariya. Ba a buƙatar 'yan Burtaniya yin allurar rigakafi a Burtaniya tare da irin jabs ɗin da aka yi da Indiya don keɓewa.

Ministan Harkokin Waje Subrahmanyam Jaishankar ya fada a cikin tweet a yau bayan ganawa da takwaransa na Burtaniya Liz Truss a New York, inda dukkansu ke halartar Babban Taron Majalisar Dinkin Duniya.

Matakin na Burtaniya na iya kuma haifar da ramuwar gayya daga New Delhi, inda wani jami'in gwamnatin Indiya ya ce akwai yiwuwar ta dauki matakan mayar da martani idan ba a gaggauta warware batun ba.

Sakataren Harkokin Wajen Indiya Harsh Vardhan Shringla ya ce "Babban batun shi ne, ga allurar rigakafi - Covishield - wanda ke da lasisi na wani kamfanin Burtaniya da aka ƙera a Indiya wanda muka ba UK allurai miliyan biyar. ya fadawa manema labarai a New Delhi.

Da yake kiran rashin amincewa da Covishield "manufar nuna wariya", ya ce ana tattaunawa da Burtaniya kan sabbin bukatun.

"Amma idan ba mu sami gamsuwa ba za mu kasance cikin 'yancinmu don sanya matakan daidaitawa."

Babbar Hukumar Burtaniya a New Delhi ta ce Burtaniya tana aiki tare da Indiya don warware matsalar.

Dokar, wacce ke ba da umarnin keɓe kai na kwanaki 10 ga matafiya da ke zuwa daga Indiya, ta kuma shafi sauran ƙasashe da yawa ta amfani da Covishield, gami da yawancin na Afirka.

Print Friendly, PDF & Email

Game da marubucin

Harry Johnson

Harry Johnson ya kasance editan aikin eTurboNews na kusan shekaru 20. Yana zaune a Honolulu, Hawaii, kuma asalinsa daga Turai ne. Yana jin daɗin rubutu da ɗaukar labarai.

Leave a Comment